RWA Wealth Partners LLC Takes $458,000 Position in Aflac Incorporated (NYSE:AFL)

RWA Wealth Partners LLC purchased a new position in shares of Aflac Incorporated (NYSE:AFL) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 5,548 shares of the financial services provider’s stock, valued at approximately $458,000.

Other hedge funds have also bought and sold shares of the company. Vanguard Group Inc. increased its position in shares of Aflac by 1.1% during the 3rd quarter. Vanguard Group Inc. now owns 54,208,007 shares of the financial services provider’s stock valued at $4,160,465,000 after purchasing an additional 605,210 shares during the last quarter. Morgan Stanley increased its holdings in Aflac by 9.0% during the third quarter. Morgan Stanley now owns 9,643,531 shares of the financial services provider’s stock worth $740,141,000 after buying an additional 794,784 shares during the last quarter. Northern Trust Corp raised its position in Aflac by 5.3% in the third quarter. Northern Trust Corp now owns 7,295,810 shares of the financial services provider’s stock worth $559,953,000 after acquiring an additional 368,704 shares during the period. Invesco Ltd. boosted its stake in Aflac by 5.0% in the third quarter. Invesco Ltd. now owns 4,808,289 shares of the financial services provider’s stock valued at $369,036,000 after acquiring an additional 227,516 shares during the last quarter. Finally, Guinness Asset Management LTD boosted its stake in Aflac by 2.3% in the third quarter. Guinness Asset Management LTD now owns 2,236,241 shares of the financial services provider’s stock valued at $171,659,000 after acquiring an additional 49,479 shares during the last quarter. 67.44% of the stock is currently owned by institutional investors.

Insider Activity at Aflac

In other Aflac news, Director Masatoshi Koide sold 30,493 shares of the company’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $79.91, for a total value of $2,436,695.63. Following the transaction, the director now directly owns 86,090 shares in the company, valued at approximately $6,879,451.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Aflac news, Director Arthur Reginald Collins sold 3,000 shares of the business’s stock in a transaction that occurred on Thursday, February 22nd. The shares were sold at an average price of $79.73, for a total value of $239,190.00. Following the completion of the transaction, the director now owns 5,592 shares of the company’s stock, valued at approximately $445,850.16. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Masatoshi Koide sold 30,493 shares of the stock in a transaction on Friday, February 16th. The stock was sold at an average price of $79.91, for a total transaction of $2,436,695.63. Following the completion of the transaction, the director now directly owns 86,090 shares in the company, valued at approximately $6,879,451.90. The disclosure for this sale can be found here. Over the last quarter, insiders sold 46,493 shares of company stock valued at $3,765,706. Company insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on AFL. Evercore ISI lowered shares of Aflac from an “in-line” rating to an “underperform” rating and raised their price target for the stock from $76.00 to $78.00 in a research note on Thursday, January 4th. Wells Fargo & Company lowered their target price on Aflac from $83.00 to $81.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 11th. Piper Sandler increased their price target on Aflac from $90.00 to $95.00 and gave the stock an “overweight” rating in a research note on Friday, April 5th. Keefe, Bruyette & Woods lifted their price objective on Aflac from $83.00 to $87.00 and gave the stock a “market perform” rating in a report on Wednesday, April 10th. Finally, Raymond James upped their price objective on shares of Aflac from $83.00 to $88.00 and gave the company an “outperform” rating in a report on Friday, February 2nd. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Aflac currently has a consensus rating of “Hold” and an average price target of $82.15.

Aflac Price Performance

Shares of NYSE:AFL opened at $83.73 on Friday. The company has a 50 day moving average of $82.61 and a 200 day moving average of $81.71. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.33. The stock has a market cap of $48.18 billion, a P/E ratio of 10.80, a P/E/G ratio of 2.30 and a beta of 0.91. Aflac Incorporated has a 12 month low of $64.10 and a 12 month high of $86.26.

Aflac (NYSE:AFL) last announced its quarterly earnings results on Thursday, February 1st. The financial services provider reported $1.25 EPS for the quarter, missing the consensus estimate of $1.47 by ($0.22). The firm had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $4.44 billion. Aflac had a net margin of 24.92% and a return on equity of 17.59%. During the same period in the previous year, the business earned $1.29 earnings per share. As a group, sell-side analysts forecast that Aflac Incorporated will post 6.41 EPS for the current fiscal year.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.